Parkinson’s Disease Cerebrospinal Fluid
About: Parkinson’s Disease Cerebrospinal Fluid (CSF) is used for studying alpha-synuclein biology and neurodegenerative pathways.
| Lot Number | Condition | Race/Ethnicity | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|
| 78011 | Parkinson's Disease | Male | Turkey |
Diltizem 90 mg once daily, Ator 20 mg once daily
|
1 | $1,800.00 | ||
| 78012 | Parkinson's Disease | Female | Turkey | 1 | $1,800.00 | |||
| 78013 | Parkinson's Disease | Female | Turkey |
Levotiron 25 mg once daily
|
1 | $1,800.00 | ||
| 78014 | Parkinson's Disease | Male | Turkey | 1 | $1,800.00 | |||
| 78015 | Parkinson's Disease | Female | Turkey |
Levotiron 25 mg once daily
|
1 | $1,800.00 | ||
| 78016 | Parkinson's Disease | Male | Turkey | 1 | $1,800.00 | |||
| 78017 | Parkinson's Disease | Male | Turkey | 1 | $1,800.00 | |||
| 78018 | Parkinson's Disease | Female | Turkey |
Diltizem 90 mg once daily, Ator 20 mg once daily
|
1 | $1,800.00 | ||
| 78019 | Parkinson's Disease | Female | Turkey | 1 | $1,800.00 | |||
| 78020 | Parkinson's Disease | Male | Turkey |
Ventolin 100 mcg once daily
|
1 | $1,800.00 |
Parkinson’s Disease Cerebrospinal Fluid (CSF)
CSF samples for alpha-synuclein and neurodegenerative biomarker research
Parkinson’s disease cerebrospinal fluid (CSF) is widely used to study alpha-synuclein aggregation and other biomarkers associated with neurodegeneration and disease progression.
Product Features
- Collected from clinically diagnosed Parkinson’s donors in Turkey
- Collected via lumbar puncture under IRB-approved protocols
- Annotated with demographic data and infectious disease testing
Applications
- Alpha-synuclein biomarker studies
- Disease progression monitoring
- Drug development and therapeutic research
Quality & Compliance
- IRB-approved collection
- Standardized processing and QC
Ordering Information
Available as in-stock CSF samples. For orders outside of the United States or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability.
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Cerebrospinal Fluid cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.